St. John's Wort (Hypericum Perforatum) -
Is it Safe during Breastfeeding?

 

 Buy Article Permissions and Reprints

Both doctors and patients often treat postnatal depression with herbal preparations derived from St. John's wort. Because these preparations are available to patients as “natural” over-the-counter drugs for depression, they are popularly assumed to be safe. However, no systematic information exists regarding treatment of postnatal depression, infant's safety or pharmacokinetics of hypericum constituents in human breast milk or infant plasma. A mother with post-natal depression was admitted at our service. Her pharmacist had recommended taking a St. John's wort preparation three times a day (Jarsin® 300, Lichtwer Pharma AG, Berlin, Germany). Four breast-milk samples (fore and hind milk) during an 18-hour period were analyzed to measure concentration of hypericin and hyperforin. Only hyperforin is excreted into breast milk at a low level, hyperforin and hypericin (two major active components) were below the lower limit of quantification (BLQ: below lower limit of quantification, LQ hypericin: 0.20 ng/ml, LQ hyperforin: 0.50 ng/ml) in this infant's plasma. No side effects were seen in the mother or infant. Before recommending St John's wort for the treatment of depression to women who breastfeed, long-term studies of outcome in infants are needed.

References

• 1 Ernst E. Second thoughts about safety of St. John's wort.  Lancet. 1999;  354 2014-2016
  CrossrefPubMedGoogle Scholar
• 2 Lee A, Ravinder M, Shinya I. Safety of St. John's wort during breastfeeding.  American Society for Clinical Pharmacology and Therapeutics. 2000;  67 130
  PubMedGoogle Scholar
• 3 Biber A, Fischer H, Romer A, Chatterjee S S. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.  Pharmacopsychiatry. 1998;  31 (1) 36-43
  PubMedGoogle Scholar
• 4 Kerb R, Brockmöller J, Staffeldt B, Ploch M, Roots I. Single-dose and Steady-State pharmacokinetics of hypericin and pseudohypericin.  Antimicrob Agents Chemother. 1996;  40 (9) 2087-2093
  PubMedGoogle Scholar
• 5 Yoshida K, Smith B, Kumar R. Psychotropic drugs in mother's milk: a comprehensive review of assay methods, pharmacokinetics and of safety of breastfeeding.  J Psychopharmacol. 1999;  13 (1) 64-80
  PubMedGoogle Scholar
• 6 Rayburn W F, Dix Christensen H, Gonzalez C L. Effect of antenatal exposure to Saint John's wort (hypericum) on neurobehavior of developing mice.  Am J Obstet Gynecol. 2000;  183 (1) 1225-1231
  CrossrefPubMedGoogle Scholar

M.D. Claudia M. Klier

Department of Psychiatry, University of Vienna, General Hospital

Währinger-Gürtel 18 - 20

1090 Vienna

Austria

Fax: (+43) (1) 40400-3605

Email: claudia.klier@univie.ac.at